Search research articles
Contact Us
Filters
Showing results (21-30 of 315) with videos related to
Page
of 32
Sort By:
Anti-Cancer Drugs
|
September 1, 2007
Radioimmunotherapy of refractory or relapsed Hodgkin's lymphoma with 90Y-labelled antiferritin antibody
Didier Decaudin, Raphaël Levy, François Lokiec, et al.
Fertility and Sterility
|
June 22, 2014
Toward a better follow-up of ovarian recovery in young women after chemotherapy with a hypersensitive antimüllerian hormone assay
Christine Decanter, Maeliss Peigne, Audrey Mailliez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 26, 2018
Through the Glass Ceiling
Hervé Tilly, Gilles Salles, Thierry J Molina, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 13, 2009
Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma
Thomas Cazaentre, Franck Morschhauser, Maximilien Vermandel, et al.
Blood
|
May 4, 2018
Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil
Charles Herbaux, Reid Merryman, Steven Devine, et al.
Leukemia & Lymphoma
|
February 27, 2020
Prognostic value of the metabolic bulk volume in patients with diffuse large B-cell lymphoma on baseline <sup>18</sup>F-FDG PET-CT
Gauthier Delaby, Marc-Antoine Hubaut, Franck Morschhauser, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 1, 2005
Testicular natural killer T-cell lymphoma
Charles Ballereau, Xavier Leroy, Franck Morschhauser, et al.
Current Hematologic Malignancy Reports
|
June 23, 2012
Early interim PET scans in diffuse large B-cell lymphoma: can there be consensus about standardized reporting, and can PET scans guide therapy choices?
Rene-Olivier Casasnovas, Michel Meignan, Alina Berriolo-Riedinger, et al.
Leukemia & Lymphoma
|
January 10, 2025
gneSeqCOO: a novel method for classifying diffuse large B-cell lymphoma cell of origin based on bulk tumor RNA sequencing profiles
Will Harris, Yi Cao, Franck Morschhauser, et al.
Blood Reviews
|
July 19, 2022
Taking the EZ way: Targeting enhancer of zeste homolog 2 in B-cell lymphomas
Franck Morschhauser, Gilles Salles, Connie Lee Batlevi, et al.
Page
of 32
Search research articles
Search
Showing results (21-30 of 315) with videos related to
Sort By:
Page
of 32
Anti-Cancer Drugs
|
September 1, 2007
Radioimmunotherapy of refractory or relapsed Hodgkin's lymphoma with 90Y-labelled antiferritin antibody
Didier Decaudin, Raphaël Levy, François Lokiec, et al.
Fertility and Sterility
|
June 22, 2014
Toward a better follow-up of ovarian recovery in young women after chemotherapy with a hypersensitive antimüllerian hormone assay
Christine Decanter, Maeliss Peigne, Audrey Mailliez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 26, 2018
Through the Glass Ceiling
Hervé Tilly, Gilles Salles, Thierry J Molina, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 13, 2009
Pre-therapy 18F-FDG PET quantitative parameters help in predicting the response to radioimmunotherapy in non-Hodgkin lymphoma
Thomas Cazaentre, Franck Morschhauser, Maximilien Vermandel, et al.
Blood
|
May 4, 2018
Recommendations for managing PD-1 blockade in the context of allogeneic HCT in Hodgkin lymphoma: taming a necessary evil
Charles Herbaux, Reid Merryman, Steven Devine, et al.
Leukemia & Lymphoma
|
February 27, 2020
Prognostic value of the metabolic bulk volume in patients with diffuse large B-cell lymphoma on baseline <sup>18</sup>F-FDG PET-CT
Gauthier Delaby, Marc-Antoine Hubaut, Franck Morschhauser, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 1, 2005
Testicular natural killer T-cell lymphoma
Charles Ballereau, Xavier Leroy, Franck Morschhauser, et al.
Current Hematologic Malignancy Reports
|
June 23, 2012
Early interim PET scans in diffuse large B-cell lymphoma: can there be consensus about standardized reporting, and can PET scans guide therapy choices?
Rene-Olivier Casasnovas, Michel Meignan, Alina Berriolo-Riedinger, et al.
Leukemia & Lymphoma
|
January 10, 2025
gneSeqCOO: a novel method for classifying diffuse large B-cell lymphoma cell of origin based on bulk tumor RNA sequencing profiles
Will Harris, Yi Cao, Franck Morschhauser, et al.
Blood Reviews
|
July 19, 2022
Taking the EZ way: Targeting enhancer of zeste homolog 2 in B-cell lymphomas
Franck Morschhauser, Gilles Salles, Connie Lee Batlevi, et al.
Page
of 32